Home
    Disclaimer
    MBDB molecular structure

    MBDB Stats & Data

    Eden Methyl-j
    NPS DataHub
    MW243.73
    FormulaC12H18ClNO2
    CAS128767-12-4
    IUPAChydrogen [1-(2H-1,3-benzodioxol-5-yl)butan-2-yl](methyl)amine chloride
    SMILES[Cl-].CCC(NC)Cc1ccc2OCOc2c1.[H+]
    InChIKeyLFXXIXAVEJVYGY-UHFFFAOYSA-N
    Phenethylamines; 2020/1. Von 2-Phenethylamin abgeleitete Verbindungen; 2021/1. Von 2-Phenethylamin abgeleitete Verbindungen; 2022/1. Von 2-Phenethylamin abgeleitete Verbindungen
    Psychoactive Class Psychedelic / Stimulant

    Effect Profile

    Curated + 15 Reports
    Psychedelic 2.4

    Strong body load with mild visuals, low headspace

    Visual Intensity×3
    5
    Headspace Depth×3
    1
    Auditory Effects×1
    0
    Body Load / Somatic Effects×1
    9
    Empathogen 4.6

    Moderate stimulation, sensory enhancement, and euphoria with low empathy

    Empathy / Social Openness×3
    2
    Euphoria / Mood Elevation×2
    6
    Stimulation×1
    7
    Sensory Enhancement×1
    7
    Stimulant 4.8

    Strong anxiety/jitters with moderate stimulation and euphoria, mild focus

    Stimulation / Energy×3
    6
    Euphoria / Mood Lift×2
    6
    Focus / Productivity×2
    4
    Anxiety / Jitters×1
    10

    Tolerance & Pharmacokinetics

    drugs.wiki

    Tolerance Decay

    Full tolerance 1h Half tolerance 10d Baseline ~14d

    Experience Report Analysis

    Erowid
    15 Reports
    1995–2004 Date Range
    20 Effects Detected

    Demographics

    Gender Distribution

    Reports Over Time

    Effect Analysis

    Erowid

    Effects aggregated from 15 experience reports (15 Erowid)

    15 Reports
    20 Effects Detected
    9 Positive
    7 Adverse
    4 Neutral

    Effect Sentiment Distribution

    Confidence Distribution

    Positive Effects 9

    Introspection 66.7% 70%
    Empathy 66.7% 70%
    Tactile Enhancement 60.0% 70%
    Euphoria 40.0% 70%
    Stimulation 33.3% 70%
    Music Enhancement 33.3% 70%
    Color Enhancement 26.7% 70%
    Body High 20.0% 70%
    Focus Enhancement 20.0% 70%

    Adverse Effects 7

    Jaw Clenching 40.0% 70%
    Anxiety 40.0% 70%
    Headache 33.3% 70%
    Sweating 33.3% 70%
    Confusion 33.3% 70%
    Pupil Dilation 26.7% 70%
    Nausea 20.0% 70%

    Real-World Dose Distribution

    62K Doses

    From 19 individual dose entries

    Oral (n=13)

    Median: 185.0mg 25th: 180.0mg 75th: 200.0mg 90th: 250.0mg
    mg/kg median: 2.513 mg/kg 75th: 2.853

    Form / Preparation

    Most common forms and preparations reported

    Body-Weight Dosing

    Dose relative to body weight from reports with weight data

    Median: 2.841 mg/kg IQR: 2.456–4.243 mg/kg n=8

    Redose Patterns

    Redosing behavior across 13 reports

    23.1% Redosed
    1.2 Avg Doses
    ← Back to MBDB